HomeNRX • CVE
add
Nurexone Biologic Inc
Previous close
$0.71
Day range
$0.71 - $0.74
Year range
$0.48 - $0.87
Market cap
57.73M CAD
Avg Volume
22.74K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.70M | 84.78% |
Net income | -1.68M | -82.00% |
Net profit margin | — | — |
Earnings per share | -0.02 | — |
EBITDA | -1.66M | -83.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 588.00K | -81.94% |
Total assets | 2.14M | -48.33% |
Total liabilities | 824.00K | 61.25% |
Total equity | 1.32M | — |
Shares outstanding | 78.01M | — |
Price to book | 35.50 | — |
Return on assets | -185.55% | — |
Return on capital | -270.61% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.68M | -82.00% |
Cash from operations | -986.00K | 32.70% |
Cash from investing | -32.00K | 86.72% |
Cash from financing | 910.00K | -79.31% |
Net change in cash | -112.00K | -104.13% |
Free cash flow | -407.38K | -1,043.51% |
About
Founded
2011
Website
Employees
12
